Nothing Special   »   [go: up one dir, main page]

AU2491095A - Compositions and methods for inhibiting growth or replication of viruses - Google Patents

Compositions and methods for inhibiting growth or replication of viruses

Info

Publication number
AU2491095A
AU2491095A AU24910/95A AU2491095A AU2491095A AU 2491095 A AU2491095 A AU 2491095A AU 24910/95 A AU24910/95 A AU 24910/95A AU 2491095 A AU2491095 A AU 2491095A AU 2491095 A AU2491095 A AU 2491095A
Authority
AU
Australia
Prior art keywords
replication
viruses
compositions
methods
inhibiting growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24910/95A
Inventor
Laure Aurelian
Paul O.P. Ts'o
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
University of Maryland at Baltimore
Original Assignee
Johns Hopkins University
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, University of Maryland at Baltimore filed Critical Johns Hopkins University
Publication of AU2491095A publication Critical patent/AU2491095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1133—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against herpetoviridae, e.g. HSV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/312—Phosphonates
    • C12N2310/3125—Methylphosphonates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU24910/95A 1990-09-21 1995-07-07 Compositions and methods for inhibiting growth or replication of viruses Abandoned AU2491095A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58618590A 1990-09-21 1990-09-21
US586185 1990-09-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU87566/91A Division AU8756691A (en) 1990-09-21 1991-09-18 Compositions and methods for inhibiting growth or replication of viruses

Publications (1)

Publication Number Publication Date
AU2491095A true AU2491095A (en) 1995-11-02

Family

ID=24344663

Family Applications (2)

Application Number Title Priority Date Filing Date
AU87566/91A Abandoned AU8756691A (en) 1990-09-21 1991-09-18 Compositions and methods for inhibiting growth or replication of viruses
AU24910/95A Abandoned AU2491095A (en) 1990-09-21 1995-07-07 Compositions and methods for inhibiting growth or replication of viruses

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU87566/91A Abandoned AU8756691A (en) 1990-09-21 1991-09-18 Compositions and methods for inhibiting growth or replication of viruses

Country Status (8)

Country Link
EP (1) EP0656942A1 (en)
JP (1) JPH06501162A (en)
AU (2) AU8756691A (en)
CA (1) CA2092711A1 (en)
IE (1) IE913321A1 (en)
IL (1) IL99543A0 (en)
NZ (1) NZ239883A (en)
WO (1) WO1992005284A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2089476A1 (en) * 1990-08-15 1992-02-16 Bernard Roizman Inhibition of herpesviridae infection by antisense oligonucleotides
WO1994001551A1 (en) * 1992-07-02 1994-01-20 United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of inhibiting viral replication
CA2105595A1 (en) * 1992-09-23 1994-03-24 Ramaswamy Narayanan Antisense polynucleotides
FR2708270B1 (en) * 1993-07-28 1995-10-20 Genset Sa Antisense oligonucleotides directed against Herpes Simplex virus types 1 & 2.
DE4331670A1 (en) * 1993-09-17 1995-03-23 Hoechst Ag Antisense oligonucleotides against HSV-1 and the preparation thereof
ATE188479T1 (en) * 1994-06-01 2000-01-15 Hybridon Inc BRANCHED OLIGONUCLEOTIDES AS PATHOGENE INHIBITING AGENTS
US7176303B2 (en) 2003-11-06 2007-02-13 Isis Pharmaceuticals, Inc. Modulation of STAT5 expression
WO2024113302A1 (en) * 2022-12-01 2024-06-06 深圳先进技术研究院 Grna targeting hsv essential genes, crispr/cas gene editing system, delivery system, and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ209840A (en) * 1983-10-17 1988-11-29 Kaji Akira A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
AU636573B2 (en) * 1988-02-26 1993-05-06 Worcester Foundation For Biomedical Research, Inc. Inhibition of htlv-iii by exogenous oligonucleotides
US5004810A (en) * 1988-09-30 1991-04-02 Schering Corporation Antiviral oligomers

Also Published As

Publication number Publication date
CA2092711A1 (en) 1992-03-22
IE913321A1 (en) 1992-02-25
JPH06501162A (en) 1994-02-10
NZ239883A (en) 1993-10-26
EP0656942A1 (en) 1995-06-14
WO1992005284A1 (en) 1992-04-02
IL99543A0 (en) 1992-08-18
AU8756691A (en) 1992-04-15
EP0656942A4 (en) 1998-04-15

Similar Documents

Publication Publication Date Title
AU2407492A (en) Compounds and methods for inhibition of hiv and related viruses
AU1460192A (en) Method and compositions for inducing bone growth
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU4387689A (en) Unpleasant taste masking compositions and methods for preparing same
AU6110990A (en) Use of viruses against undesirable micro-organisms
IL117873A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
AU9040491A (en) Method for the isolation and purification of taxane derivatives
AU2260088A (en) Methods and compositions for the treatment of lung conditions
ZA962879B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
IL117876A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
AU5872294A (en) Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells
AU2065992A (en) Herbicidal compositions and methods of preparing and using the same
AU1448092A (en) Splitter and method of forming it
AU8044491A (en) Antitumor compositions and methods of treatment
AU3586395A (en) Methods and compositions for inhibiting production of replication competent virus
ZA962878B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
HUP9900901A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
ZA962880B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
AU6125890A (en) Method and composition for destroying or inhibiting growth of microorganisms
AU8155394A (en) Methods of inhibiting Turner's syndrome
AU2491095A (en) Compositions and methods for inhibiting growth or replication of viruses
AU636741B2 (en) Treatment of plants for frost protection
AU5183490A (en) Composition for the inhibition of tumors and for the non-cytotoxic inhibition of replication of viruses
AU8920191A (en) Methods and compositions for minimizing inhibition of nucleic acid amplification
AU6962894A (en) Compositions and methods for inhibiting replication of human immunodeficiency virus-1